Cephalosporin induced coagulopathies.
D000328:Adult; D000368:Aged; D001760:Bleeding Time; D001791:Blood Platelet Disorders / Q000139:chemically induced*; D002511:Cephalosporins / Q000009:adverse effects*; D002648:Child; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced* / Q000188:drug therapy; D007223:Infant; D009070:Moxalactam / Q000009:adverse effects*; D010314:Partial Thromboplastin Time; D010974:Platelet Aggregation / Q000187:drug effects; D011517:Prothrombin Time; D010837:Vitamin K 1 / Q000627:therapeutic use; D014813:Vitamin K Deficiency / Q000139:chemically induced* / Q000188:drug therapy
D002511:Cephalosporins; D010837:Vitamin K 1; D009070:Moxalactam